Cancer Aug 8, 2019
Expanding access to a promising but costly treatment, Medicare said Wednesday it will cover for some blood cancers a breakthrough gene therapy that revs up a patient’s own immune cells to destroy malignancies. Officials said Medicare will cover CAR-T cell therapies for certain types of lymphoma and leukemia. The cost of the treatments can run to hundreds of thousands of.